ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter

Japan and Western drugmakers launch $1bn fund against superbugs

Takeda, Glaxo and Amgen among 23 names uniting to fight antibiotic resistance

A magnified image of methicillin-resistant Staphylococcus aureus bacteria: drug-resistant diseases kill about 700,000 people a year across the world.   © Reuters

TOKYO -- Drugmakers from Japan, the U.S. and Europe have announced a more than $1 billion fund to invest in startups developing treatments for antibiotic-resistant infections.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more